BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10026282)

  • 1. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
    Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
    Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
    Mikol V; LoGrasso PV; Boettcher BR
    J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
    Chitayat S; Kanelis V; Koschinsky ML; Smith SP
    Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
    Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
    Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
    Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
    Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
    J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
    Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
    Chang Y; Mochalkin I; McCance SG; Cheng B; Tulinsky A; Castellino FJ
    Biochemistry; 1998 Mar; 37(10):3258-71. PubMed ID: 9521645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL.
    Caterer NR; Graversen JH; Jacobsen C; Moestrup SK; Sigurskjold BW; Etzerodt M; Thøgersen HC
    Biol Chem; 2002 Nov; 383(11):1743-50. PubMed ID: 12530539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
    Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
    Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.
    Christen MT; Frank P; Schaller J; Llinás M
    Biochemistry; 2010 Aug; 49(33):7131-50. PubMed ID: 20617841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding.
    Ye Q; Rahman MN; Koschinsky ML; Jia Z
    Protein Sci; 2001 Jun; 10(6):1124-9. PubMed ID: 11369850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10.
    Rahman MN; Becker L; Petrounevitch V; Hill BC; Jia Z; Koschinsky ML
    Biochemistry; 2002 Jan; 41(4):1149-55. PubMed ID: 11802713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
    Chang Y; Zajicek J; Castellino FJ
    Biochemistry; 1997 Jun; 36(25):7652-63. PubMed ID: 9201906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural assessment of the apo[a] protein of human lipoprotein[a].
    Guevara J; Knapp RD; Honda S; Northup SR; Morrisett JD
    Proteins; 1992 Feb; 12(2):188-99. PubMed ID: 1318546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
    Edelstein C; Mandala M; Pfaffinger D; Scanu AM
    Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
    Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
    Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.